Skip to Main Content

Author Details

Kei Sato
The Institute of Medical Science, The University of Tokyo
2008
86
29
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34968415The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.Cell Rep2022
37848618Single-cell transcriptome analysis illuminating the characteristics of species-specific innate immune responses against viral infections.Gigascience2022
35468127Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.PLoS Comput Biol2022
35568035Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.Cell2022
35551519A hominoid-specific endogenous retrovirus may have rewired the gene regulatory network shared between primordial germ cells and naïve pluripotent cells.PLoS Genet2022
33064816A patient infected with SARS-CoV-2 over 100 days.QJM2021
33765414Sarbecovirus ORF6 proteins hamper induction of interferon signaling.Cell Rep2021
33789992Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.J Virol2021
33762419Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins.J Virol2021
33613459Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection.Front Microbiol2021
33774510Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution.Virology2021
34887501The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production.Sci Rep2021
34551301An additional NF-κB site allows HIV-1 subtype C to evade restriction by nuclear PYHIN proteins.Cell Rep2021
34488225SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.Nature2021
34171266SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.Cell Host Microbe2021
34260717SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.J Infect Dis2021
33477360The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.Viruses2021
33230872HIV-1 tracing method of systemic viremia in vivo using an artificially mutated virus pool.Microbiol Immunol2021
32493363A tissue level atlas of the healthy human virome.BMC Biol2020
31843890Retroviruses drive the rapid evolution of mammalian <i>APOBEC3</i> genes.Proc Natl Acad Sci U S A2020
32067146Inherited chromosomally integrated HHV-6 possibly modulates human gene expression.Virus Genes2020
33087347Endogenous retroviruses drive KRAB zinc-finger protein family expression for tumor suppression.Sci Adv2020
33168808Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells.Nat Commun2020
32941788SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.Cell Rep2020
32913367A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans.PLoS Pathog2020
32668246Multiomics Investigation Revealing the Characteristics of HIV-1-Infected Cells In Vivo.Cell Rep2020
32611749Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.J Virol2020
32335137Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model.J Theor Biol2020
31133753N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation.Nat Microbiol2019
30915053Comparative Description of the Expression Profile of Interferon-Stimulated Genes in Multiple Cell Lineages Targeted by HIV-1 Infection.Front Microbiol2019
29212937Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.J Virol2018
29636069New World feline APOBEC3 potently controls inter-genus lentiviral transmission.Retrovirology2018
29611801A naturally occurring feline APOBEC3 variant that loses anti-lentiviral activity by lacking two amino acid residues.J Gen Virol2018
29691441Author Correction: Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model.Sci Rep2018
29379496Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.Front Immunol2018
29300152Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species.J Gen Virol2018
29324226Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.Cell Host Microbe2018
28761140Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model.Sci Rep2017
28084671Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.Genes Cells2017
28482907A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.Retrovirology2017
28331087Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.J Virol2017
28475648HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.PLoS Pathog2017
28346011Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.Exp Biol Med (Maywood)2017
29162867Broad-spectrum antiviral agents: secreted phospholipase A<sub>2</sub> targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.Sci Rep2017
28880964Correction: HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.PLoS Pathog2017
27086687Quantifying the effect of Vpu on the promotion of HIV-1 replication in the humanized mouse model.Retrovirology2016
28484185Investigation of HIV-1 pathogenesis using humanized mouse model.Uirusu2016
29624319[Interplay between HIV-1 and APOBEC].Seikagaku2016
26507442Dynamics of HIV infection in lymphoid tissue network.J Math Biol2016
27665724A naturally occurring bovine APOBEC3 confers resistance to bovine lentiviruses: implication for the co-evolution of bovids and their lentiviruses.Sci Rep2016
  • 1 - 50 of 86

Recommended Authors

Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Ferdinand Roesch
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year 2009
Number of shared co-authors 1
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Michael Nekorchuk
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 1
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 1
Stef??n R J??nsson
Institute for Experimental Pathology, University of Iceland
Career Start Year 2005
Number of shared co-authors 2
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 2
Rebecca S LaRue
Minnesota Supercomputing Institute, University of Minnesota
Career Start Year 2003
Number of shared co-authors 2
Keisuke Shindo
Graduate School of Medicine, Kyoto University
Career Start Year 2002
Number of shared co-authors 3
Felipe Diaz-Griffero
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Priya S Shah
University of California davis
Career Start Year 2002
Number of shared co-authors 1
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 1
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 2
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 0
Greg J Towers
University College London
Career Start Year 1995
Number of shared co-authors 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 2
Lubbertus C F Mulder
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 1
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 0
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 3
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 3
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 1
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 2
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 1

Collaborators

Reuben S Harris
University of Texas Health San Antonio
Co-authored papers 5
Gideon Schreiber
Co-authored papers 4
Kotaro Shirakawa
Graduate School of Medicine, Kyoto University
Co-authored papers 3
Michael A Carpenter
University of Minnesota
Co-authored papers 1
Zachary Ardern
Wellcome Trust Sanger Institute
Co-authored papers 1
Alexander E Gorbalenya
Leiden University Medical Center
Co-authored papers 1
Manolis Kellis
Massachusetts Institute of Technology
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Noah Stern
Weizmann Institute of Science
Co-authored papers 1
Françoise Clavel-Chapelon
Co-authored papers 1
John Ziebuhr
Institute of Medical Virology Justus Liebig University
Co-authored papers 1
Chase W Nelson
Biodiversity Research Center, Taiwan Institute for Comparative Genomics
Co-authored papers 1
Irwin Jungreis
Broad Institute of MIT and Harvard
Co-authored papers 1
Yaara Finkel
Weizmann Institute of Science
Co-authored papers 1
Andrew E Firth
University of Cambridge
Co-authored papers 1
Daron M Standley
Osaka university
Co-authored papers 1
Wei Shao
Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 1
Ronald G Collman
University of Pennsylvania School of Medicine
Co-authored papers 1
Beatrice H Hahn
Co-authored papers 1
Simon Langer
University Hospital of Wurzburg
Co-authored papers 1
Angelo Pavesi
University of Parma
Co-authored papers 1
Release 1.2